{"id":8573,"date":"2023-07-19T10:49:46","date_gmt":"2023-07-19T08:49:28","guid":{"rendered":"https:\/\/www.estiv.org\/congress2024\/general-information-copy\/"},"modified":"2024-06-04T16:41:46","modified_gmt":"2024-06-04T14:41:46","slug":"programme","status":"publish","type":"page","link":"https:\/\/www.estiv.org\/congress2024\/programme\/","title":{"rendered":"Programme"},"content":{"rendered":"\n<p>The complete ESTIV 2024 programme including practical information is now available. Download the programme below. The full programme does not include the poster list. For poster information we kindly refer to the Poster Page by clicking <a href=\"https:\/\/www.estiv.org\/congress2024\/posters\/\" class=\"ek-link\">here<\/a>.<\/p>\n\n\n\n<div class=\"block-buttons alignwide is-content-justification-center is-layout-flex block-buttons-is-layout-flex\">\n<div class=\"block-button\"><a class=\"block-button__link\" href=\"https:\/\/www.estiv.org\/content\/uploads\/2024\/05\/estiv004_program_a4_240524.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">DOWNLOAD FULL PROGRAMME<\/a><\/div>\n<\/div>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<p>The abstract book can be found <a href=\"https:\/\/www.estiv.org\/congress2024\/abstract-book\/\" target=\"_blank\" aria-label=\"here (opens in a new tab)\" rel=\"noreferrer noopener\" class=\"ek-link\">here<\/a>.<\/p>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<ul class=\"editorskit-no-desktop editorskit-no-tablet editorskit-no-mobile block-list\"><li><a href=\"#ECHA\" class=\"ek-link\">ECHA, EMA and EFSA perspective#ECHAs on the use of NAMs \/ Funding the development, validation, and implementation of NAMs<\/a><\/li><li><a href=\"#2a\" class=\"ek-link\">Models, biomarkers and assays for endocrine disruption&nbsp;&nbsp;<\/a><\/li><li><a href=\"#2b\" class=\"ek-link\">Challenges in cosmetics safety\u202f<\/a>&nbsp;<\/li><li><a href=\"#3a\" class=\"ek-link\">Models, biomarkers and assays for systemic and immune toxicity\u202f&nbsp;<\/a><\/li><li><a href=\"#3b\" class=\"ek-link\">Organ-on-a-chip &amp; Microphysiological Systems<\/a>\u202f<a href=\"https:\/\/www.estiv.org\/admin\/post.php?post=8573&amp;action=edit#1\">&nbsp;<\/a><\/li><li><a href=\"#4a\" class=\"ek-link\">Computational toxicology \u2013 in silico modelling, read-across, artificial intelligence and machine learning<\/a><a href=\"https:\/\/www.estiv.org\/admin\/post.php?post=8573&amp;action=edit#1\">\u202f<\/a><a href=\"https:\/\/www.estiv.org\/admin\/post.php?post=8573&amp;action=edit#1\">&nbsp;<\/a><\/li><li><a href=\"#4b\" class=\"ek-link\">Local toxicity testing (safety and efficacy)&nbsp;<\/a><\/li><li><a href=\"#IS\" class=\"ek-link\">Industry session &#8211; In vitro inhalation toxicity and future trends for Fiber Safety assessment<\/a><\/li><li><a href=\"#PRV\" class=\"ek-link\">Peer Review for Validation Studies &#8211; building confidence and transparency into a new validation paradigm<\/a><\/li><li><a href=\"#5a\" class=\"ek-link\">Non-animal methods for safety testing of biopharmaceuticals\/biotherapies\/vaccines\u202f&nbsp;<\/a><\/li><li><a href=\"#5b\" class=\"ek-link\">Knowledge sharing and education<\/a><\/li><li><a href=\"#6a\" class=\"ek-link\">Toxicokinetics and in vitro \u2013 in vivo extrapolation<\/a><a href=\"https:\/\/www.estiv.org\/admin\/post.php?post=8573&amp;action=edit#1\">&nbsp;<\/a><\/li><li><a href=\"#6b\" class=\"ek-link\">In vitro systems to assess respiratory toxicity&nbsp;<\/a><\/li><li><a href=\"#6c\" class=\"ek-link\">Bio-engineering, stem cells and disease models\u202f<\/a>&nbsp;<\/li><li><a href=\"#6d\" class=\"ek-link\">Towards Liver models <\/a><\/li><li><a href=\"#8a\" class=\"ek-link\">Models, biomarkers and assays for developmental toxicity\u202f&nbsp;<\/a><\/li><li><a href=\"#9a\" class=\"ek-link\">Cardiotoxicity and cardiac efficacy models&nbsp;<\/a><\/li><li><a href=\"#7a\" class=\"ek-link\">Case studies for successful use and implementation of complex in vitro models<\/a><\/li><li><a href=\"#7a\" class=\"ek-link\">Complex chemical mixtures &#8211; how can NAMs contribute?<\/a><\/li><li><a href=\"#8b\" class=\"ek-link\">Regulatory considerations for complex NAMs&nbsp;<\/a><\/li><li><a href=\"#9a\" class=\"ek-link\">In vitro and in silico methods for safety assessment of medical devices\u202f<\/a><\/li><li><a href=\"#Early1\" class=\"ek-link\">Early Stage Researcher Session 1<\/a><\/li><li><a href=\"#Early2\" class=\"ek-link\">Early Stage Researcher Session 2<\/a><\/li><li><a href=\"#Debate\" class=\"ek-link\">Debate session<\/a><\/li><li><a href=\"#Career\" class=\"ek-link\">Career development session<\/a>&nbsp;<\/li><\/ul>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"has-text-align-center block-heading\">Instructions for Oral and Poster Presenters<\/h2>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<div class=\"block-buttons is-content-justification-center is-layout-flex block-buttons-is-layout-flex\">\n<div class=\"block-button\"><a class=\"block-button__link\" href=\"https:\/\/www.estiv.org\/content\/uploads\/2024\/05\/20240529-estiv-2024-instructions-for-oral-presenters-ad-v5.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Oral presentations<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<div class=\"block-buttons is-content-justification-center is-layout-flex block-buttons-is-layout-flex\">\n<div class=\"block-button\"><a class=\"block-button__link\" href=\"https:\/\/www.estiv.org\/content\/uploads\/2024\/05\/estiv-2024-instructions-for-poster-presenters-v4.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Poster presentations<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<div class=\"block-buttons is-content-justification-center is-layout-flex block-buttons-is-layout-flex\">\n<div class=\"block-button\"><a class=\"block-button__link\" href=\"https:\/\/www.estiv.org\/congress2024\/print-service-information\/\" target=\"_blank\" rel=\"noreferrer noopener\">Poster print services<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<h2 class=\"has-text-align-center block-heading\">ESTIV Accepted posters list <\/h2>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\"><\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<div class=\"block-buttons is-content-justification-center is-layout-flex block-buttons-is-layout-flex\">\n<div class=\"block-button\"><a class=\"block-button__link\" href=\"https:\/\/www.estiv.org\/content\/uploads\/2024\/05\/estiv-2024-poster-list-v3.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Poster list<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\"><\/div>\n<\/div>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<div class=\"block-buttons is-content-justification-center is-layout-flex block-buttons-is-layout-flex\"><\/div>\n\n\n\n<p><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<div class=\"block-buttons is-content-justification-right is-layout-flex block-buttons-is-layout-flex\"><\/div>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<h2 class=\"has-text-align-center block-heading\">Draft Scientific Programme &#8211; Session details <\/h2>\n\n\n\n<p class=\"has-text-align-center\">The programme may still be subject to minor changes <\/p>\n\n\n\n<h2 class=\"alignfull has-text-align-center block-heading\"> Monday, June 3rd, 2024<\/h2>\n\n\n\n<div class=\"block-image\"><figure class=\"alignright size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.estiv.org\/content\/uploads\/2023\/12\/pre-congress-ws.png\" alt=\"\" class=\"wp-image-9373\" width=\"197\" height=\"148\" srcset=\"https:\/\/www.estiv.org\/content\/uploads\/2023\/12\/pre-congress-ws.png 1352w, https:\/\/www.estiv.org\/content\/uploads\/2023\/12\/pre-congress-ws-600x452.png 600w\" sizes=\"auto, (max-width: 197px) 100vw, 197px\" \/><\/figure><\/div>\n\n\n\n<p>09:00-13:00: <span class=\"has-inline-color has-green-color\"><strong><a href=\"https:\/\/www.estiv.org\/congress2024\/pre-congress-workshop\/\" class=\"ek-link\">Pre-conference workshop<\/a><\/strong> <\/span>-How to write and manage a successful EU Horizon proposal: From initial idea to execution (organised with ONTOX)<br>                    <em>Chairs: Prof Mathieu Vinken (VUB, Brussels, Belgium)  &amp; Dr Helena Kandarova  <\/em>(<em><em><em>CEM SAS, Bratislava, Slovakia) <\/em><\/em><\/em>   <\/p>\n\n\n\n<p>13:00-14:00: Lunch break<\/p>\n\n\n\n<p>14:00-14:20: <strong>Opening Ceremony of the ESTIV 2024<\/strong> <strong>Congress<\/strong> <br>                     <a href=\"https:\/\/www.xplosion.sk\/home\/\" class=\"ek-link\">XPLOSION Violin Trio<\/a><br>                     <em>Chairs: Dr Helena Kandarova (CEM SAS, Bratislava, Slovakia) &amp; Dr&nbsp;Clive Roper&nbsp;(Roper Toxicology Consulting Limited, Edinburgh, UK)<\/em><\/p>\n\n\n\n<p>14:20-15:00: <strong><span class=\"has-inline-color has-green-color\">Keynote lecture I <\/span><\/strong>&#8211; <strong><a href=\"https:\/\/www.estiv.org\/congress2024\/invited-speakers\/\" class=\"ek-link\">PD Dr. Robert Landsiedel, DABT, FATS<\/a><\/strong> &#8211;<strong> Star Wars on Ceres.&nbsp;Episode I<\/strong> &#8211; The irreproducibility menace<br>                   <em>  Chairs: Dr Helena Kandarova (CEM SAS, Bratislava, Slovakia) &amp; Dr&nbsp;Clive Roper&nbsp;(Roper Toxicology Consulting Limited, Edinburgh, UK)<\/em> <br>                     <\/p>\n\n\n\n<p>15:00-16:00 <strong><span class=\"has-inline-color has-green-color\">ESTIV Early Scientific Career Award ceremony 2024 <\/span>and Lecture<\/strong><br>                    <em>Chairs: Dr<em><em> Helena Kandarova  (CEM SAS, Bratislava, Slovakia) &amp;  <em>Dr&nbsp;Clive Roper&nbsp;(Roper Toxicology Consulting Limited, Edinburgh, UK)<\/em>  <\/em><\/em><\/em><\/p>\n\n\n\n<p>16:00-16:30: Coffee break, visiting exhibition area &amp; poster viewing<br><\/p>\n\n\n\n<p><b id=\"ECHA\">16:30-18:30<\/b>: <strong>Session 1 &#8211; <strong>ECHA, EMA and EFSA perspectives on the use of NAMs<\/strong> \/ <strong>Funding the development, validation, and implementation of NAMs<\/strong><\/strong><br>                     <em>Chairs: Dr Costanza Rovida (TEAM mastery S.r.l., Como, Italy) <\/em>&amp; <em>Dr&nbsp;Clive Roper&nbsp;(Roper Toxicology Consulting Limited, Edinburgh, UK)   <\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Costanza Rovida<\/strong> &#8211; Counting the number of animals that REACH and CLP are requesting as the first step to start accepting NAMs<\/li><li><strong>Lucian Farcal<\/strong> &#8211; Guidance on the use of biomarkers of effect in regulatory risk assessment of chemicals &#8211; integration of new approach methodologies<\/li><li><strong>Maria Chiara<\/strong> <strong>Astuto<\/strong> &#8211; EFSA\u2019s ongoing and planned activities in the application of NAMs for the risk assessment of chemicals<\/li><li><strong>Taina Palosaari<\/strong> &#8211; Accelerating Validation through In Vitro Method Automation and High Throughput Testing<\/li><li><strong>Philippe Hubert<\/strong> &#8211; Validating NAMs: Experience gained on the PEPPER Platform<\/li><\/ul>\n\n\n\n<p class=\"has-text-align-center\"><em>   <\/em><br> <strong>18:30-20:00<\/strong>: Welcome reception &amp; <strong>Poster session I<\/strong><\/p>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<h2 class=\"alignfull has-text-align-center block-heading\">Tuesday, June 4th, 2024<\/h2>\n\n\n\n<p> <strong>08:30-09:00<\/strong> <span class=\"has-inline-color has-green-color\"><strong>Keynote Lecture II<\/strong> <\/span>&#8211; <strong><a href=\"https:\/\/www.estiv.org\/congress2024\/invited-speakers\/\" class=\"ek-link\">Prof. Dr. Theo M. de Kok, ERT<\/a><\/strong> &#8211; Safety assessment of the food additives without animal testing: Case study &#8211; E171 (titanium dioxide) . <\/p>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><strong>0<\/strong><b id=\"2a\"><strong>9:00-10:30:&nbsp;Session 2a \u2013 Models, biomarkers and assays for endocrine disruption<\/strong><br><\/b><em><strong><b id=\"2a\">Chairs:  Christian Pellevoisin (Urbilateria &amp; Vitroscreen,<\/b> France)<b id=\"2a\"> and Prof Arno Gutleb (Invitrolize &amp; Luxembourg Institute of Science and Technology LIST, Luxembourg, Luxembourg) <\/b><\/strong><\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Daniela Lange<\/strong> &#8211; Evaluation of in vitro and in silico new alternative methods for the identification of potential endocrine effects<\/li><li><strong>Christian Pellevoisin<\/strong> &#8211; A 3d model applicable to reproductive toxicology<\/li><li><strong>Kim Heikamp<\/strong> &#8211; Human based brain barrier models for studying thyroid hormone transport<\/li><li><strong>Petra Miku\u0161ov\u00e1<\/strong> &#8211; The identification of thyroid hormone-disrupting chemicals from complex environmental mixtures using pull-down assay coupled with non-target analysis<\/li><li><strong>Runze Liu<\/strong> &#8211; Novel in vitro assay for thyroperoxidase inhibition \u2013 comparison of different models and detection methods<\/li><\/ul>\n\n\n\n<p><\/p>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p id=\"2b\"><strong>09:00-10:30:&nbsp;Session 2b&nbsp;\u2013&nbsp;Challenges in cosmetics safety<\/strong><br><em>Chairs:<\/em> <em> <em>Dr Bambou Tan<\/em>  <em>(<em>L&#8217;Or\u00e9al<\/em>, Paris, France)<\/em> <\/em>and <em>Erin Hill (ICCS, New York<\/em>, <em>USA)  <\/em><br><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Andy Forreryd<\/strong>&nbsp;&#8211; Improved confidence of quantitative sensitizing potency assessment for point of departure using Gardskin dose-response<\/li><li><strong>Fleur Tourneix<\/strong>&nbsp; &#8211; Deriving a continous point of departure for skin sensitization assessment using a bayesian network model&nbsp;&nbsp;<\/li><li><strong>Johanna Ebmeyer<\/strong> &#8211; A novel 3d Nrf2-are reporter epidermis model for skin sensitization testing<\/li><\/ul>\n\n\n\n<p><br> <\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"block-separator aligncenter\"\/>\n\n\n\n<p class=\"has-text-align-center\">  <strong>10:30-11:00<\/strong>: Coffee break, visiting exhibition area &amp; poster viewing <\/p>\n\n\n\n<hr class=\"block-separator aligncenter\"\/>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><b id=\"3a\"><strong>11:00-13:00: Session 3a \u2013 Human Cells as&nbsp;New Approach Methodologies&nbsp;for&nbsp;Immunotoxicity Testing<\/strong> <br><em>Chairs: <\/em><\/b><em><b id=\"3a\">Dr Victor J. Johnson<\/b> (Burleson Research Technologies, Inc., Morrisville, NC, USA) and Prof  Emanuela Corsini (Universit\u00e0 degli Studi di Milano, Milan Italy)<\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Victor J. Johnson<\/strong>&nbsp;&nbsp;&#8211; Building a comprehensive toolbox for Immunotoxicology safety assessment using human whole blood.<\/li><li><strong>Emanuela Corsini<\/strong> &#8211; Using <em>in vitro<\/em> human immune system models to understand the immunotoxicity risks associated with PFAS exposure<\/li><li><strong>Fenna Sill\u00e9 &#8211; <\/strong>A Path Forward: Current and Future Perspectives of Alternatives to Developmental Immunotoxicity Testing<\/li><li><strong>Norbert E. Kaminski<\/strong> &#8211; Human cord blood derived CD34+ hematopoietic stem cells as an in vitro model for investigating developmental immunotoxicity<\/li><li><strong>M\u00e9lanie Mourot-Bousquenaud &#8211; <\/strong>In vitro assessment of the sensitizing potential of bisphenol A substitutes<\/li><\/ul>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p id=\"3b\"><strong>11:00-13:00: Session 3b \u2013 Organ-on-a-chip<\/strong> <strong>&amp; Microphysiology systems<\/strong> <br><em>Chairs: <strong> <\/strong><em>Dr Beno\u00eet Maisonneuve (NETRI, Lyon, France)<\/em>  and Dr Erika Ferrari <\/em>(<em>BiomimX, Milano, Italy)<\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Erika Ferrari <\/strong>&#8211; Evaluating the potential of novel physiologic-like liver-on-chip models for in vitro hepatotoxicity screening<\/li><li><strong>Kaushal Joshi<\/strong> &#8211; A pilot study to evaluate the kinetics, metabolism, and toxicity of a fragrance material (coumarin) in an in vitro three-organ integrated microphysiological system (MPS) model<\/li><li><strong>Maria-Jose Ruiz<\/strong> &#8211;  Cytotoxic effects induced by individual and combined exposure to sterigmatocystin, ochratoxin A, and patulin on sh-sy5y spheroids<\/li><li><strong>Marie-Gabrielle Zurich<\/strong> &#8211; Novel strategy to assess the neurotoxicity of organic solvents such as glycol ethers: combining in vitro and in silico methods with human-controlled exposure experiments<\/li><li><strong>Ovidiu Novac<\/strong> &#8211; A sensitive and robust human liver microphysiological system for assessing drug-induced liver injury<\/li><li><strong>Eileen Hallscheidt<\/strong> &#8211; Oral absorption and intestinal first-pass metabolism of pesticides using an in vitro human gut-model<\/li><\/ul>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p> <strong>13:00-14:00:<em> <\/em><\/strong>Lunch break, visiting exhibition area &amp; poster viewing <\/p>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<div class=\"block-image\"><figure class=\"alignright is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/aspis-cluster.eu\/wp-content\/uploads\/2023\/02\/ASPIS-Academy-logo-300x143.png\" alt=\"\" width=\"197\" height=\"94\"\/><\/figure><\/div>\n\n\n\n<p id=\"ILSI\"><strong><strong>13:00-14:00:<\/strong><\/strong> <strong><a href=\"https:\/\/www.estiv.org\/shaping-the-future-of-chemical-risk-assessment-insights-from-aspis-academy\/\" class=\"ek-link\"><span class=\"has-inline-color has-green-color\">ASPIS Training Academy session<\/span><\/a><\/strong> &#8211; Organised by Early Career scientists of ONTOX, RiskHunt3Rs and PrecisionTox    <br><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><b id=\"4a\"><strong>14:00-16:00: Session 4a \u2013 Computational toxicology \u2013 in silico modelling, read-across, artificial intelligence<\/strong><br><\/b><em><b id=\"4a\">Chairs: Prof Thomas Hartung (Johns Hopkins Bloomberg School of Public Health and the Whiting School of Engineering, Baltimore<\/b>, USA)<\/em> <em>and Emily Reinke (Inotiv, Research Triangle Park, NC, United States<\/em>)<em> <\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Emily Reinke <\/strong>&#8211; Case studies for the sara-ice defined approach for skin sensitization \u2013 application to different chemistries<\/li><li><strong>Fresnais Louison <\/strong>&#8211; Metabolic mechanisms of action modelling to sustain safety evaluation of cosmetic ingredients<\/li><li><strong>Prachi Pradeep<\/strong> &#8211; New approach methods for regulatory risk assessment of azo dyes in textiles<\/li><li><strong>Simon Perera del Rosario<\/strong> &#8211; Anthrodrugs-tox: personalized toxicology through population genetics<\/li><li><strong>Vijay Gombar<\/strong> &#8211; Integration of multi-domain data and interpretable in-silico models for computational toxicology <\/li><\/ul>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p id=\"4b\"><strong>14:00-16:00:&nbsp;Session 4b \u2013 Local toxicity testing (safety and efficacy)<\/strong> <br><em>Chairs: Dr Helena Kandarova (CEM SAS, Bratislava, Slovakia)  and Dr Eugene Choi (OECD, Paris, France) <\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Marco Pelin<\/strong> &#8211; Adoption of OECD TG 439 and 431 for the assessment of skin irritation and corrosion properties of 2D nanomaterials<\/li><li><strong>Maria Laura<\/strong> <strong>Gutierrez <\/strong>&#8211; Eye damage reversibility in an in vitro model of bovine cornea to replace the Draize test completely<\/li><li><strong>Rodrigo Azevedo Loiola<\/strong> &#8211; The Interleukin-18 is an in vitro biomarker for the prediction of photosensitization in reconstructed human epidermis: the development of photosensil-18 method for the safety assessment of raw materials and finished products<\/li><li><strong>V\u00e9rane Bard<\/strong> &#8211; Toxicity of polylactic acid and polyethylene terephthalate nanoplastics, aged in environmental conditions, on human intestinal cells<\/li><\/ul>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<p class=\"has-text-align-center\"> <b>16:00-16:30<\/b>: Coffee break, visiting exhibition area &amp; poster viewing <\/p>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><b id=\"Early1\"><strong>16:30-17:30:&nbsp;Early Stage Researcher Session 1<\/strong><br><\/b><em><b id=\"Early1\">Chairs: <\/b><strong> Marketa Dvo\u0159\u00e1kov\u00e1 (NIPH Prague, Praha, Czech Republic) and Mohamed Fathi Abdallah Abdelmohsen<\/strong> (Ghent University, Ghent, Belgium)<\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Arunima Sengupta<\/strong> &#8211; A new lung-on-chip inhalation platform for toxicity and therapy assessment<\/li><li><strong>Eli\u0161ka \u0158eh\u016f\u0159kov\u00e1<\/strong> &#8211; Utilizing human induced pluripotent stem cells to enhance in vitro leydig cell models for reproductive health research<\/li><li><strong>Eli\u0161ka Sychrov\u00e1<\/strong> &#8211; Male reproductive toxicity of real-life PFAS mixtures: an AOP-based investigation<\/li><li><strong>Giulia De Negri Atanasio<\/strong> &#8211; Evaluation of physiological repeated exposure of aluminium in a 3d intestinal tissue model<\/li><\/ul>\n\n\n\n<p><\/p>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><b id=\"IS\"><strong>16:30-17:30:&nbsp;Industry session &#8211; In vitro inhalation toxicity and future trends for Fiber Safety assessment <\/strong><br><em>Chairs<\/em><\/b><em><b id=\"IS\">: <\/b><strong> <\/strong>Prof <em><b id=\"2a\">Arno Gutleb (Invitrolize &amp; Luxembourg Institute of Science and Technology LIST, Luxembourg, Luxembourg) <\/b><\/em> and Dr Samuel Constant (Epithelix, Plan-les-Ouates, Switzerland)<strong>  <\/strong><\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Amy Madl <\/strong>&#8211; Toxicology of synthetic vitreous fibers (svfs): Historical overview and outlook for next generation new approach methods (NAMs)<\/li><li><strong>Annette Bitsch<\/strong> &#8211; The problem of lung overload in animal studies<\/li><li><strong>Samuel Constant <\/strong>&#8211; Advanced immunocompetent in vitro primary human lung models for point-of-contact toxicity evaluation of man-made vitreous fibres (mmvf)<\/li><\/ul>\n\n\n\n<p><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><b id=\"Early2\"><strong>17:30-18:30:&nbsp;Early Stage Researcher Session 2<\/strong><br> <em>Chairs:  <em>Marketa Dvo\u0159\u00e1kov\u00e1<\/em> <em>(NIPH Prague, Praha, Czech Republic)<\/em> <strong>and<\/strong>  <em><strong>Mohamed Fathi Abdallah Abdelmohsen<\/strong> (Ghent University, Ghent, Belgium<\/em> <\/em><\/b><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Ignacio Risue\u00f1o<\/strong> -A novel way to measure cell viability with electrochemical sensing for in vitro skin testing<\/li><li><strong>Julia N\u00f6th <\/strong>-Analysis of vascular disruptors in zebrafish embryos &#8211; an endpoint of developmental toxicity<\/li><li><strong>Krupansh Desai<\/strong> -In vitro biocompatibility assessment of engineered living materials: a high throughput strategy<\/li><li><strong>Laurie Perdigon<\/strong> -Successful generation of three-dimensional human precision-cut lung slices for pulmonary fibrosis modeling<\/li><li><strong>Liyi Tan &#8211;<\/strong> Toxic effects of metal oxide nanoparticles on healthy and psoriatic-like human epidermal keratinocytes<\/li><li><strong>Peter P\u00f4bi\u0161<\/strong> &#8211; Development of sensitive in vitro protocols for biocompatibility testing of medical devices and pharmaceuticals intended for contact with eyes:<\/li><\/ul>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p id=\"PRV\"><strong>17:30-19:30:&nbsp;Peer Review for Validation Studies &#8211; building confidence and transparency into a new validation paradigm<\/strong><br> <em>Chairs: Amanda Ulrey (IIVS, Gaithersburg, USA) and Jo\u00e3o Barroso (JRC, Ispra, Italy) <\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Jo\u00e3o Barroso<\/strong> -The art of validation and peer review: evolving practices while ensuring scientific confidence<\/li><li><strong>G. Frank Gerberick<\/strong> &#8211; Ensuring transparency and rigor in the peer review of new approach methods for skin sensitization assessment<\/li><li><strong>Herv\u00e9 Groux<\/strong> &#8211; Peer review for validation studies &#8211; building confidence and transparency into a new validation paradigm- the test developer perspective<\/li><li><strong>Sebastian Hofmann <\/strong>&#8211; Comprehensive reporting of validation studies starts at inception and ends with peer review<\/li><li><strong>Amanda Ulrey<\/strong> &#8211; Assessing data integrity: a deep dive into data review in method validation<\/li><li><strong>Emily Reinke<\/strong> &#8211; Peer review for validation studies &#8211; building confidence and transparency into a new validation paradigm<\/li><\/ul>\n<\/div>\n<\/div>\n\n\n\n<p class=\"has-text-align-center\" id=\"Career\"><\/p>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<p class=\"has-text-align-center\"><strong>18:30<\/strong> &#8211; <strong>19:30<\/strong>: <strong>ESTIV General Assembly <\/strong><br><strong>Poster Session II <\/strong><br><em>Participants with <strong><span style=\"text-decoration: underline;\"><span style=\"text-decoration: underline;\" class=\"ek-underline\">even-numbered posters<\/span><\/span><\/strong> are required to be physically present at their posters for presentation and questions during this poster session<\/em>.<\/p>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<h2 class=\"alignfull has-text-align-center block-heading\">Wednesday, June 5th, 2024<\/h2>\n\n\n\n<p>  <strong>08:30-09:00<\/strong> <span class=\"has-inline-color has-green-color\"><strong>Keynote Lecture II<\/strong>I <\/span>&#8211; <strong><a href=\"https:\/\/www.estiv.org\/congress2024\/invited-speakers\/\" class=\"ek-link\">Prof. Mathieu Vinken<\/a><\/strong> &#8211; Ontologies as the basis for setting up animal-free test batteries: liver toxicity as a case study<\/p>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><strong>0<\/strong><b id=\"5a\"><strong>9:00-10:30:&nbsp;Session 5a &#8211; PARC session &#8211; Partnership for the Assessment of Risks from Chemicals <\/strong><br><\/b><em><b id=\"5a\">Chairs:  <\/b>Prof Denis Sarigiannis (Aristotle University of Thessaloniki, Greece) and prof Philip Marx-Stoelting  (German Federal Institute for Risk Assessment, Berlin, Germany)<\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Denis Sarigiannis <\/strong>&#8211; Safe and Sustainable by Design<\/li><li><strong>Gilles Riviere<\/strong> &#8211; Hazard Assessment in PARC<\/li><li><strong>Sebastian Schmeisser<\/strong> &#8211; NGRAroute andd PARCopedia<\/li><li><strong>Dimitra Nikolopoulou <\/strong>&#8211; How PARC can contribute to promoting the regulatory uptake of NAMs <\/li><\/ul>\n\n\n\n<p><\/p>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p id=\"5b\"><strong>09:00-10:30:&nbsp;Session 5b&nbsp;\u2013&nbsp;Knowledge sharing and education<\/strong><br><em>Chairs:<\/em> Dr. <em>Bambou Tan (LOreal, Paris, France) and Erin Hill (ICCS, New York, USA) <\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Bambou Xuezhu TAN<\/strong> &#8211; Storytelling skills for a more effective scientific communication<\/li><li><strong>Beta Montemayer &#8211; <\/strong>Skills for Next-Generation Safety Scientists in Cosmetics: Bridging Academic Expertise to Industry Relevance<\/li><li><strong>Erin Hill<\/strong> &#8211; International Collaboration for Cosmetics Safety (ICCS): Accelerating Global Adoption of Animal-Free Safety Science for Cosmetic Product and Ingredient Safety Assessment<\/li><li><strong>Philipp Paulitschke<\/strong> &#8211; New non-invasive, label-free monitoring approach for 2D and 3D cell culture<\/li><li><strong>Pascale Mora<\/strong> &#8211;  Continuing education for next-generation risk assessment<\/li><\/ul>\n\n\n\n<p><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<p class=\"has-text-align-center\"> <strong>10:30-11:00<\/strong>: Coffee break, visiting exhibition area &amp; poster viewing<br> <\/p>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><b id=\"6a\"><strong>1<\/strong><\/b><strong><b id=\"6a\">1:00-13:00:&nbsp;Session 6a \u2013 Toxicokinetics and&nbsp;in vitro\u2013in vivo&nbsp;extrapolation<br><em>Chairs:<\/em> <em>Jochem Louisse (European Food Safety Authority EFSA, Parma, Italy) and Andreas Schepky<\/em> <\/b><em><b id=\"6a\">(Beiersdorf AG, Hamburg, Germany<\/b>)<\/em><\/strong><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Andreas Schepky<\/strong> &#8211; Relevance of Toxicokinetics and ADME methods in Quantifying Exposure for Next generation Risk Assessment<\/li><li><strong>Daniela Brenner<\/strong> &#8211; Toxicokinetic assessment of perfluorooctanoic acid and perfluorooctanesulfonic acid in a 2-dimensional in vitro liver model<\/li><li><strong>Elena Reale<\/strong> &#8211;  Next-generation risk assessment for diterpene glycosides<\/li><li><strong>Evita Vandenbossche-Goddard<\/strong> &#8211; A workflow for true dose considerations of in vitro test systems which are used as part of next-generation risk assessment<\/li><li><strong>Ren\u00e9 Geci &#8211; <\/strong>High-throughput PBK modelling providing insights into ADME\/TK in systemic toxicity<\/li><li><strong>Jochem Louisse<\/strong> &#8211; Towards a quantitative interpretation of in vitro DNT data using PBK-modelling based QIVIVE<\/li><\/ul>\n\n\n\n<p><\/p>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p id=\"6b\"><strong>11:00-13:00 Session 6b&nbsp;\u2013&nbsp;In vitro systems to assess respiratory toxicity<\/strong><br><em>Chairs:<\/em> <em> Prof <em><strong><b id=\"2a\">Arno Gutleb (Invitrolize &amp; Luxembourg Institute of Science and Technology LIST, Luxembourg, Luxembourg) <\/b><\/strong><\/em>and Robert Bedford <\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Robert Bedford &#8211; <\/strong>An In Vitro Model to Mimic Immune and Vascular Responses Following Airway Inflammation in Humans<\/li><li><strong>Sabina Burla<\/strong> &#8211; Responses insided by AEROSIL\u00ae R 504 using ALISENS\u00ae<\/li><li><strong>Sonia Scarf\u00ec<\/strong> &#8211; Inflammatory and carcinogenic potential of mineral fibres assessed through a physiologically relevant 3d in vitro model of human alveolar tissue<\/li><li><strong>Xiao-Yann<\/strong> <strong>Huang<\/strong> &#8211; Development of an in vitro model of Dry Nose<\/li><li><strong>Sylvain Billet<\/strong> &#8211; Toxicity of mixtures: ethylbenzene and xylene have competitive effects in human lung cells<\/li><li><strong>Nienke Ruijter<\/strong> &#8211; The Sabyna in vitro hazard testing strategy for adverse effects upon inhalation of nanomaterials: \u2018safe and sustainable by design\u2019 made practical<\/li><\/ul>\n\n\n\n<p><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><strong>13:00-14:00:&nbsp;Lunch break, visiting<\/strong> <strong>exhibition area &amp; poster viewing<\/strong><\/p>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<div class=\"block-image\"><figure class=\"alignright size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.estiv.org\/content\/uploads\/2024\/05\/image-6.png\" alt=\"\" class=\"wp-image-10882\" width=\"171\" height=\"171\" srcset=\"https:\/\/www.estiv.org\/content\/uploads\/2024\/05\/image-6.png 578w, https:\/\/www.estiv.org\/content\/uploads\/2024\/05\/image-6-128x128.png 128w, https:\/\/www.estiv.org\/content\/uploads\/2024\/05\/image-6-76x76.png 76w, https:\/\/www.estiv.org\/content\/uploads\/2024\/05\/image-6-452x452.png 452w\" sizes=\"auto, (max-width: 171px) 100vw, 171px\" \/><\/figure><\/div>\n\n\n\n<p><strong>13:00-14:00:&nbsp;Session organised by <\/strong><span class=\"has-inline-color has-green-color\"><strong><strong>The Centre for Animal-Free [Proefdiervrij] Biomedical Translation<\/strong><\/strong>: <strong><a href=\"https:\/\/www.estiv.org\/cpbt-the-centre-for-animal-free-proefdiervrij-biomedical-translation-session-co-creating-a-lifelong-learning-program\/\" class=\"ek-link\">Co-creating a life long training program <\/a><\/strong><\/span><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<p class=\"has-text-align-center\">  <\/p>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p id=\"6c\"><strong>14:00-15:00 <strong>Session 7a- Bio-engineering, stem cells and disease models<\/strong><\/strong><\/p>\n\n\n\n<p><em><b id=\"6a\">Chairs:  Dr Yasunari&nbsp;Kanda&nbsp;(National Institute of Health Sciences, Kawasaki, Japan)  and Prof  Anna Maria Bassi, (Universita degli Studi di Genova, Genova, Italy)  <\/b><\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Anna Maria Bassi<\/strong> &#8211; Differentiation of retinal organoids from human iPSC&nbsp; for modelling&nbsp; neurodegenerative diseases<\/li><li><strong>Yasunari Kanda<\/strong> &#8211; Prediction of developmental neurotoxicity using an integrated in silico and in vitro approach. <\/li><li><strong>Alexandra Gatzios<\/strong>&#8211; Genetic predisposition for anti-mash drug response:&nbsp; a population-based in vitro study<\/li><\/ul>\n\n\n\n<p><\/p>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p id=\"6d\"> <strong>14:00-15:00 <strong>Session 7b- Towards Liver models<\/strong><\/strong><\/p>\n\n\n\n<p><em>Chairs:<\/em> <em>Mathieu Vinken (VUB, Brussels, Belgium)  and Amer Jamalpoor (Toxys, Oegstgeest, The Netherlands)<\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Anna Melina Steinbach<\/strong> &#8211; Towards in silico modelling of qAOPs for liver steatosis<\/li><li><strong>Heeseung Jo<\/strong> &#8211; A framework for a chemically agnostic model for liver injury as a stepping stone to link in vitro outcomes to organ-level adverse outcomes.<\/li><li><strong>Alkiviadis Stagkos-Georgiadis<\/strong> &#8211; Prioritisation of potential hepatotoxic co-formulants for chemical risk assessment using NAMs<\/li><li><strong>Anouk Verhoeven<\/strong>&nbsp;&nbsp;&#8211; A stem cell-based in vitro test battery to predict liver steatotic potential of diverse chemicals<\/li><\/ul>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<div class=\"block-image\"><figure class=\"alignright size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.estiv.org\/content\/uploads\/2024\/03\/round-table-.png\" alt=\"\" class=\"wp-image-10113\" width=\"151\" height=\"147\" srcset=\"https:\/\/www.estiv.org\/content\/uploads\/2024\/03\/round-table-.png 708w, https:\/\/www.estiv.org\/content\/uploads\/2024\/03\/round-table--464x452.png 464w\" sizes=\"auto, (max-width: 151px) 100vw, 151px\" \/><figcaption>DALLE for ESTIV<\/figcaption><\/figure><\/div>\n\n\n\n<p class=\"has-text-align-center\" id=\"Debate\"><strong>15:00-16:00<\/strong>: <span class=\"has-inline-color has-green-color\"><strong><a href=\"https:\/\/www.estiv.org\/debate-session-and-panel-discussion\/\" class=\"ek-link\">Debate session and Panel discussion<\/a><\/strong><\/span><strong><strong><a href=\"https:\/\/www.estiv.org\/debate-session-and-panel-discussion\/\" class=\"ek-link\">:  Future of the validation process &#8211; where do we stand? <\/a><\/strong><\/strong><\/p>\n\n\n\n<p class=\"has-text-align-center\" id=\"Debate\">Debate on the recent development and sustainability of concepts of validation studies with experts from industry, regulatory fields, EURL-ECVAM and NGOs<br> <em><em><em><em><em> <\/em><\/em><\/em><\/em><\/em> <\/p>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<p class=\"has-text-align-center\"> <strong>16:00-16:30<\/strong>: Coffee break, visiting exhibition area &amp; poster viewing <\/p>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><b id=\"7a\"><strong>16:30<\/strong>-1<strong>8:30: &nbsp;Session 8a &#8211; Case studies for successful use and implementation of complex in vitro models <br><\/strong> <em>Chairs:<\/em> <\/b><em> Dr Andreas Stucki (PETA Science Consortium International e.V., Stuttgart, Germany)  and Paul Carmichael<span style=\"font-size; color: initial;\"> <\/span> (Unilever, UK and Wageningen University (WUR),  <em>Wageningen<\/em><\/em>, <em>The Netherlands<\/em><strong><em> <\/em> <\/strong><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Andreas O Stucki<\/strong> &#8211; The INSPIRE Initiative: Assessing respiratory toxicity of surfactants to human cell-based in vitro systems by pipetting and aerosol exposure<\/li><li><strong>Giel Hendricks<\/strong> &#8211; Validation and implementation of the toxtracker assay for mechanistic genotoxicity assessment<\/li><li><strong>Benoit Fischer<\/strong> &#8211; 2D and 3D human endothelial cell models to assess vascular toxicity<\/li><li><strong>Els Adriaens<\/strong> &#8211; Breaching the surface: in vitro Eye Hazard Assessment of surfactants based on an innovative Defined Approach<\/li><li><strong>Kristina Jochum<\/strong> &#8211; Comparative Case Studies on NAMs: A Step Towards Enhancing Specific Target Organ Toxicity Analysis<\/li><li><strong>Paul Carmichael<\/strong> -New Approach Methodologies (NAMs) for use in Next Generation Risk Assessment (NGRA) for Systemic Safety: A pragmatic approach to \u2018validation\u2019 by establishing protectiveness and utility<\/li><\/ul>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><strong>16:30-18:30 Session 8b &#8211; Complex chemical mixtures &#8211; how can NAMs contribute?<\/strong><br><em><em>Chairs:<\/em> <em> Prof Anne Marie Vinggaard (DTU, Denemark)  and Beate Escher (Helmholtz Centre for Environmental Research in Leipzig, Germany<\/em><\/em>)<em><em> <\/em><\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Anne Marie Vinggaard<\/strong> &#8211; Using NAMs for predicting adverse effects of chemical mixtures on male reproductive health<\/li><li><strong>Beate Escher<\/strong> &#8211; In vitro assays for quantification of adverse effects of chemical mixtures extracted from human serum<\/li><li><strong>Wibke Busch<\/strong> &#8211; Combined effects of pesticide product ingredients in zebrafish and mixture effect predictions at the whole transcriptome scale<\/li><li><strong>Iva&nbsp;Sovadinov\u00e1 <\/strong>&#8211; Unraveling the impact of a real-life organochlorine mixture on male reproductive health: an AOP-driven approach combined with lipidomics<\/li><li><strong>Ji\u0159\u00ed Nov\u00e1k<\/strong>&nbsp;&#8211; Endocrine disruptive potencies of air and dust samples from different indoor environments<\/li><\/ul>\n\n\n\n<p><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<p class=\"has-text-align-center\"><strong>18:30 &#8211; 19:30 <a href=\"https:\/\/www.estiv.org\/estiv-career-development-session\/\" class=\"ek-link\"><span class=\"has-inline-color has-green-color\">Career development session<\/span><\/a><\/strong> and <strong>poster session III<\/strong><br> <em>Participants with <strong><span style=\"text-decoration: underline;\"><span style=\"text-decoration: underline;\" class=\"ek-underline\">odd-numbered posters<\/span><\/span><\/strong> are required to be physically present at their posters for presentation and questions during this poster session<\/em>. <\/p>\n\n\n\n<div class=\"block-image\"><figure class=\"aligncenter size-large is-resized\"><a href=\"https:\/\/www.estiv.org\/estiv-career-development-session\/\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.estiv.org\/content\/uploads\/2024\/05\/career-session-1380x1200.jpg\" rel=\"lightbox\" alt=\"\" class=\"wp-image-11133\" width=\"186\" height=\"162\" srcset=\"https:\/\/www.estiv.org\/content\/uploads\/2024\/05\/career-session-1380x1200.jpg 1380w, https:\/\/www.estiv.org\/content\/uploads\/2024\/05\/career-session-1536x1336.jpg 1536w, https:\/\/www.estiv.org\/content\/uploads\/2024\/05\/career-session-2048x1781.jpg 2048w, https:\/\/www.estiv.org\/content\/uploads\/2024\/05\/career-session-520x452.jpg 520w\" sizes=\"auto, (max-width: 186px) 100vw, 186px\" \/><\/a><\/figure><\/div>\n\n\n\n<p class=\"has-text-align-center\"> <strong>19:30 &#8211;<\/strong><a href=\"https:\/\/www.estiv.org\/congress2024\/social-programme-2024\/\" class=\"ek-link\"> <strong>Departures to Congress dinner &amp; social evening<\/strong> <\/a><\/p>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<h2 class=\"alignfull has-text-align-center block-heading\">Thursday, June 6th, 2024<\/h2>\n\n\n\n<p class=\"has-text-align-center\"> <\/p>\n\n\n\n<p><strong>08:30 &#8211; 9:00 Keynote lecture IV <\/strong>&#8211; <a href=\"https:\/\/www.estiv.org\/congress2024\/invited-speakers\/\" class=\"ek-link\"><strong><span class=\"has-inline-color has-green-color\">Prof. Thomas Hartung<\/span><\/strong><\/a> &#8211;  Probabilistic Risk Assessment &nbsp;only becomes beautiful by AI  <\/p>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><b id=\"8a\"><strong>09:00-10:00:&nbsp;Session 9a \u2013 Developmental Toxicity and Developmental Neurotoxicity<\/strong> (DNT)<br><em>Chairs:<\/em> <\/b><em>Dr Yasunari&nbsp;Kanda&nbsp;(National Institute of Health Sciences, Kawasaki, Japan) and Dr Amer Jamalpoor<\/em> <em> (Toxys, Oegstgeest, The Netherlands)<\/em> <\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Robin Pronk<\/strong> &#8211; High-throughput screening of FDA-approved compounds on human brain organoids for safety assessment<\/li><li><strong>Jade Houghton<\/strong> &#8211; Evaluating the Reprotracker assay as a NAM for developmental and reproductive toxicity testing<\/li><li><strong>Matthew Burbank<\/strong> &#8211; Advancing the use of New Approach Methodologies for assessing teratogenicity: A tiered approach<\/li><li><strong>Chun-Wei Tung<\/strong> &#8211; Benchmarking in silico methods for identifying chemicals of developmental neurotoxicity concern<\/li><\/ul>\n\n\n\n<p><\/p>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><b id=\"8b\"><strong> <b id=\"8a\"><strong>09:00-10:00<\/strong><\/b>:&nbsp;Session 9b \u2013 Regulatory considerations for complex NAMs<\/strong><br><em>Chairs:<\/em><\/b><em><b id=\"8b\"> <\/b>Anne Gourmelon (OECD, Paris, France)  and Dr Nathalie Alepee (L&#8217;Oreal, Paris, France)<\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Nathalie Alepee<\/strong> &#8211; Quantifying the uncertainty of the new approach methodology U-SENS for skin sensitization assessment in a regulatory context<\/li><li><strong>Anne Gourmelon &#8211; <\/strong>The future of risk assessment at OECD<\/li><li><strong>Philip Marx-Stoelting<\/strong> &#8211; NAMs in chemical mixture risk assessment<\/li><li><strong>Raechel Puglisi<\/strong> &#8211; Survey results to identify nam use in agrochemical regulation<\/li><\/ul>\n<\/div>\n<\/div>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p> <b id=\"5a\"><strong>10:00-11:00:&nbsp;Session 10a \u2013&nbsp;In vitro&nbsp;methods for safety testing of biopharmaceuticals\/biotherapies\/vaccines<\/strong><br><em>Chairs:<\/em><\/b><em><b id=\"5a\"> <\/b><strong> <\/strong>Dr Yasunari&nbsp;Kanda&nbsp;(National Institute of Health Sciences, Kawasaki, Japan)  and Dr Beno\u00eet Maisonneuve (NETRI, Lyon, France)<\/em><\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Bas ter Braak<\/strong> &#8211; In vitro prediction of drug-induced liver injury using toxprofiler<\/li><li><strong>Rajamuthu Srinivasan <\/strong>&#8211; Pragmatic Approach to inculcate New Approach Methodologies (NAMs) in Vaccine Safety Assessment<\/li><li><strong>Ludovico Buti <\/strong>&#8211; Evaluation of 3d human intestinal organoids as a platform for ev-a71 antiviral drug discovery (<em>ESR presentation<\/em>)<\/li><li><strong>Josephine Blersch<\/strong> &#8211; A human ex vivo model for assessing the immunotoxicity risk of engineered nanomaterials.  <\/li><\/ul>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><b id=\"3a\"><strong>10:00-11:00:  <b id=\"Early2\"><strong>&nbsp;Early Stage Researcher Session 3<\/strong><\/b> <\/strong><\/b><\/p>\n\n\n\n<p><b id=\"3a\"><em>Chairs: <\/em><\/b><em>Dr&nbsp;Andreas&nbsp;Stucki (PETA Science Consortium International e.V., Stuttgart, Germany)<\/em> <em>and Dr Bambou Tan<\/em>  <em>(<em>L&#8217;Or\u00e9al<\/em>, Paris, France)<\/em> <\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Luiz Ladeira<\/strong> &#8211; Physiological maps and their curation guidelines: paving the way for mechanistic NGRA<\/li><li><strong>Eliska Kuchovska<\/strong> &#8211; Ontology-based AI-driven innovative approach using DNT NAMs for NGRA<\/li><li><strong>Ruchir Shah<\/strong> &#8211; Artificial intelligence (AI)-driven morphological assessment of zebrafish embryo for developmental toxicity chemical screening<\/li><li><strong>Sara Sepehri<\/strong> &#8211; A next-generation risk assessment case study for the hair dye HC Yellow 13 focused on liver steatosis<\/li><\/ul>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<p class=\"has-text-align-center\"><strong>11:00-11:30<\/strong>: Coffee break <\/p>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><b id=\"9a\"><strong>11:30-12:45:&nbsp;Session 11a \u2013&nbsp;In vitro&nbsp;methods for safety assessment of medical devices <\/strong><br><strong><em>Chairs: Helena Kandarova (CEM SAS, Bratislava, Slovakia) and Christian Pellevoisin<\/em><\/strong><\/b> <em><strong><b id=\"2a\">(Urbilateria &amp; Vitroscreen<\/b>, France)<b id=\"2a\"> <\/b><\/strong><\/em> <\/p>\n\n\n\n<ul class=\"block-list\"><li><strong>Christian Pellevoisin &#8211; <\/strong>Challenges in regulatory acceptance of NAMs for medical devices<\/li><li><strong>Andy Forreryd<\/strong> &#8211; Regulatory approval of medical devices according to MDR using in vitro data from GARDskin Medical Device for skin sensitization assessment<\/li><li><strong>Tom Meseberg<\/strong> &#8211; Developement of a macrophage-based in vitro assay for alternative prediction of foreign body reaction to implantable medical devices<\/li><li><strong>Patr\u00edcia Gomes Ruivo<\/strong> &#8211; Reproductive Toxicity of vaginal lubricants: effects on oocyte maturation, fertilization and sperm viability<\/li><\/ul>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><strong>11:30 &#8211; 12:45:&nbsp;Session 11b&nbsp;\u2013&nbsp;Cardiotoxicity and cardiac efficacy models<\/strong><br><strong><em>Chairs:<\/em><\/strong><em> Marketa Dvo\u0159\u00e1kov\u00e1<\/em> <em>(NIPH Prague, Praha, Czech Republic) and Andreas Stucki<\/em>  <em>(PETA Science Consortium In<\/em>ternational<em> e.V., Stuttgart, Germany<\/em>)  <\/p>\n\n\n\n<ul class=\"block-list\"><li><strong style=\"color: initial;\">Georgia Papadimitriou<\/strong><span style=\"color: initial;\"> &#8211; A weight of evidence approach for assessing cardiotoxicity in a regulatory context integrating New Approach Methodologies (NAMs)<\/span><\/li><li><strong>S. Rodrigues Ribeiro<\/strong> &#8211; SmartHeart &#8211; Novel cardiac-microtissues to answer the evolving challenges of drug discovery<\/li><li><strong>Laura-Sophie Frommelt<\/strong> &#8211; Green chemistry, red flags: ensuring cardiovascular safety by performing multiparametric analysis of phytochemicals using hIPSC-CMs-MEA assay.<\/li><li><strong>Niall Macquaide<\/strong> &#8211; Chronic Assessment of hERG Trafficking on Repolarisation and Cytotoxicity in iPSC Cardiomyocytes<\/li><\/ul>\n\n\n\n<p><\/p>\n<\/div>\n<\/div>\n\n\n\n<p class=\"has-text-align-center\"><strong>12:45-13:30<\/strong>:<strong> Congress closing ceremony<\/strong><br><em><em><em>                     <em>Chairs: Dr Helena Kandarova (CEM SAS, Bratislava, Slovakia) &amp; Dr&nbsp;Clive Roper&nbsp;(Roper Toxicology Consulting Limited, Edinburgh, UK)<\/em> <\/em><\/em> <\/em> <\/p>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<h2 class=\"has-text-align-center block-heading\">POST-CONFERENCE ACTIVITIES<\/h2>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><strong>14:00-19:00: <strong><span class=\"has-inline-color has-green-color\"><a href=\"https:\/\/www.estiv.org\/congress2024\/post-congress-workshop\/\" class=\"ek-link\">Post-conference workshop with EPISKIN Academy<\/a><\/span><\/strong><\/strong><\/p>\n\n\n\n<p><\/p>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><\/p>\n<\/div>\n<\/div>\n\n\n\n<hr class=\"block-separator\"\/>\n\n\n\n<h2 class=\"alignfull has-text-align-center block-heading\">Friday,  June 7th, 2024 <\/h2>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><strong>09:00-13:00:<span class=\"has-inline-color has-green-color\"> <a href=\"https:\/\/www.estiv.org\/congress2024\/post-congress-workshop\/\" class=\"ek-link\">Post-conference workshop with EpiSkin Academy<\/a><\/span><\/strong><\/p>\n<\/div>\n\n\n\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<p><\/p>\n<\/div>\n<\/div>\n\n\n\n<div class=\"block-columns is-layout-flex wp-container-core-columns-is-layout-9d6595d7 block-columns-is-layout-flex\">\n<div class=\"block-column is-layout-flow block-column-is-layout-flow\">\n<figure class=\"block-image size-full is-resized\"><a href=\"https:\/\/www.episkin.com\/\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.estiv.org\/content\/uploads\/2021\/05\/fond_webinar-v4-002.jpg\" rel=\"lightbox\" alt=\"\" class=\"wp-image-3487\" width=\"234\" height=\"197\"\/><\/a><\/figure>\n<\/div>\n<\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The complete ESTIV 2024 programme including practical information is now available. Download the programme below. The full programme does not&#8230;<\/p>\n","protected":false},"author":5,"featured_media":8515,"parent":8017,"menu_order":26,"ping_status":"closed","template":"","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":12,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","_searchwp_excluded":"","_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":[0],"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueState":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_VenueShowMap":false,"_VenueShowMapLink":false,"_core_expirator_enabled":"","_core_expirator_date":"","_yoast_wpseo_redirect":"","rank_math_redirect":"","redirect":"","_core_expirator_redirect_url":"","footnotes":""},"class_list":["post-8573","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/pages\/8573","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/users\/5"}],"version-history":[{"count":20,"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/pages\/8573\/revisions"}],"predecessor-version":[{"id":11419,"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/pages\/8573\/revisions\/11419"}],"up":[{"embeddable":true,"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/pages\/8017"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/media\/8515"}],"wp:attachment":[{"href":"https:\/\/www.estiv.org\/api\/wp\/v2\/media?parent=8573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}